Medzihradsky, Oliver F
Kleinschmidt, Immo
Mumbengegwi, Davis
Roberts, Kathryn W
McCreesh, Patrick
Dufour, Mi-Suk Kang
Uusiku, Petrina
Katokele, Stark
Bennett, Adam
Smith, Jennifer
Sturrock, Hugh
Prach, Lisa M
Ntuku, Henry
Tambo, Munyaradzi
Didier, Bradley
Greenhouse, Bryan
Gani, Zaahira
Aerts, Ann
Gosling, Roly
Hsiang, Michelle S
Clinical trials referenced in this document:
Documents that mention this clinical trial
Study protocol for a cluster randomised controlled factorial design trial to assess the effectiveness and feasibility of reactive focal mass drug administration and vector control to reduce malaria transmission in the low endemic setting of Namibia
https://doi.org/10.1136/bmjopen-2017-019294
Cost and cost effectiveness of reactive case detection (RACD), reactive focal mass drug administration (rfMDA) and reactive focal vector control (RAVC) to reduce malaria in the low endemic setting of Namibia: an analysis alongside a 2×2 factorial design cluster randomised controlled trial (Post-results)
https://doi.org/10.1136/bmjopen-2021-049050
Funding for this research was provided by:
Horchow Family Fund
Novartis Foundation for Sustainable Development
Bill and Melinda Gates Foundation